|
1
|
Smith RA, Andrews KS, Brooks D, Fedewa SA,
Manassaram-Baptiste D, Saslow D, Brawley OW and Wender RC: Cancer
screening in the United States, 2018: A review of current American
Cancer Society guidelines and current issues in cancer screening.
CA Cancer J Clin. 68:297–316. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E, et
al: The 2015 World Health Organization Classification of Lung
Tumors: Impact of Genetic, Clinical and Radiologic Advances Since
the 2004 Classification. J Thorac Oncol. 10:1243–1260.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cai J, Fang L, Huang Y, Li R, Xu X, Hu Z,
Zhang L, Yang Y, Zhu X, Zhang H, et al: Simultaneous overactivation
of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers
chemoresistance-associated metastasis in NSCLC. Nat Commun.
8(15870)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chen H and Hwang JH: Ultrasound-targeted
microbubble destruction for chemotherapeutic drug delivery to solid
tumors. J Ther Ultrasound. 1(10)2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tinkov S, Bekeredjian R, Winter G and
Coester C: Microbubbles as ultrasound triggered drug carriers. J
Pharm Sci. 98:1935–1961. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yang H, Sun Y, Wei J, Xu L, Tang Y, Yang
L, Zhang X and Lu Y: The effects of ultrasound targeted microbubble
destruction (UTMD) carrying IL 8 monoclonal antibody on the
inflammatory responses and stability of atherosclerotic plaques.
Biomed Pharmacother Oct. 118(109161)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lee Y, Jeon K, Lee JT, Kim S and Kim VN:
MicroRNA maturation: Stepwise processing and subcellular
localization. EMBO J. 21:4663–4670. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Barbato S, Solaini G and Fabbri M:
MicroRNAs in Oncogenesis and Tumor Suppression. Int Rev Cell Mol
Biol. 333:229–268. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dan B, Luo J, Li K and Chen S: Prognostic
value of miR-375 for survival outcomes in various cancers: A
systematic review and meta-analysis. Oncol Res Treat. 41:47–50.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li Y, Shen Z, Jiang H, Lai Z, Wang Z,
Jiang K, Ye Y and Wang S: MicroRNA 4284 promotes gastric cancer
tumorigenicity by targeting ten-eleven translocation 1. Mol Med
Rep. 17:6569–6575. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yang F, Nam S, Brown CE, Zhao R, Starr R,
Ma Y, Xie J, Horne DA, Malkas LH, Jove R, et al: A novel berbamine
derivative inhibits cell viability and induces apoptosis in cancer
stem-like cells of human glioblastoma, via up-regulation of
miRNA-4284 and JNK/AP-1 signaling. PLoS One.
9(e94443)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sim J, Kim Y, Kim H, Shin SJ, Kim DH, Paik
SS and Jang K: Identification of recurrence-associated microRNAs in
stage I lung adenocarcinoma. Medicine (Baltimore).
97(e10996)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sun W, Zhao P, Zhou Y, Xing C, Zhao L, Li
Z and Yuan L: Ultrasound targeted microbubble destruction assisted
exosomal delivery of miR-21 protects the heart from chemotherapy
associated cardiotoxicity. Biochem Biophys Res Commun. 532:60–67.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li X, Xu M, Lv W and Yang X:
Ultrasound-targeted microbubble destruction-mediated miR-767
inhibition suppresses tumor progression of non-small cell lung
cancer. Exp Ther Med. 19:3391–3397. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Leong-Poi H, Kuliszewski MA, Lekas M,
Sibbald M, Teichert-Kuliszewska K, Klibanov AL, Stewart DJ and
Lindner JR: Therapeutic arteriogenesis by ultrasound-mediated
VEGF165 plasmid gene delivery to chronically ischemic skeletal
muscle. Circ Res. 101:295–303. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Akhurst T: Staging of non-small-cell lung
cancer. PET Clin. 13:1–10. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Soria JC, Massard C and Le Chevalier T:
Should progression-free survival be the primary measure of efficacy
for advanced NSCLC therapy? Ann Oncol. 21:2324–2332.
2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Schwartz AG and Cote ML: Epidemiology of
lung cancer. Adv Exp Med Biol. 893:21–41. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Connell LC, Harding JJ and Abou-Alfa GK:
Advanced Hepatocellular Cancer: The Current State of Future
Research. Curr Treat Options Oncol. 17(43)2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang Z, Sha HH and Li HJ: Functions and
mechanisms of miR 186 in human cancer. Biomed Pharmacother.
119(109428)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xue L and Yang D: miR 421 inhibited
proliferation and metastasis of colorectal cancer by targeting
MTA1. J BUON. 23:1633–1639. 2018.PubMed/NCBI
|
|
25
|
Huang L, Zhang Y, Li Z, Zhao X, Xi Z, Chen
H, Shi H, Xin T, Shen R and Wang T: miR-4319 suppresses colorectal
cancer progression by targeting ABTB1. United European
Gastroenterol J. 7:517–528. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang G, Xiong G, Cao Z, Zheng S, You L,
Zhang T and Zhao Y: miR-497 expression, function and clinical
application in cancer. Oncotarget. 7:55900–55911. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ji Y, Han Z, Shao L and Zhao Y: Evaluation
of in vivo antitumor effects of low-frequency ultrasound-mediated
miRNA-133a microbubble delivery in breast cancer. Cancer Med.
5:2534–2543. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Munari E, Marchionni L, Chitre A, Hayashi
M, Martignoni G, Brunelli M, Gobbo S, Argani P, Allaf M, Hoque MO,
et al: Clear cell papillary renal cell carcinoma: micro-RNA
expression profiling and comparison with clear cell renal cell
carcinoma and papillary renal cell carcinoma. Hum Pathol.
45:1130–1138. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liu W, Wang P, Xie Z, Wang S, Ma M, Li J,
Li M, Cen S, Tang S, Zheng G, et al: Abnormal inhibition of
osteoclastogenesis by mesenchymal stem cells through the
miR-4284/CXCL5 axis in ankylosing spondylitis. Cell Death Dis.
10(188)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tamaddon G, Geramizadeh B, Karimi MH,
Mowla SJ and Abroun S: miR-4284 and miR-4484 as putative biomarkers
for diffuse large B-cell lymphoma. Iran J Med Sci. 41:334–339.
2016.PubMed/NCBI
|
|
31
|
Wu J and Li RK: Ultrasound-targeted
microbubble destruction in gene therapy: A new tool to cure human
diseases. Genes Dis. 4:64–74. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Shi D, Guo L, Sun X, Shang M, Meng D, Zhou
X, Liu X, Zhao Y and Li J: UTMD inhibit EMT of breast cancer
through the ROS/miR-200c/ZEB1 axis. Sci Rep.
10(6657)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lin L, Fan Y, Gao F, Jin L, Li D, Sun W,
Li F, Qin P, Shi Q, Shi X, et al: UTMD-Promoted Co-Delivery of
gemcitabine and miR-21 inhibitor by dendrimer-entrapped gold
nanoparticles for pancreatic cancer therapy. Theranostics.
8:1923–1939. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yang C, Li B, Yu J, Yang F, Cai K and Chen
Z: Ultrasound microbubbles mediated miR-let-7b delivery into
CD133+ ovarian cancer stem cells. Biosci Rep.
38(38)2018.PubMed/NCBI View Article : Google Scholar
|
